Filed: 2/14/2025ACC: 0001937964-25-000003
📋 What this filing means
ARTIA GLOBAL PARTNERS LP filed this quarterly 13F‑HR report disclosing 35 equity positions with a total reported market value of $279.81M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
35
Positions
$279.81M
Total AUM (reported)
5.38M
Total Shares
Allocation by class
COM$164.71M58.9%
ADR$38.71M13.8%
SPONSORED ADR$20.48M7.3%
COMMON STOCK$17.62M6.3%
SPONSORED ADS$13.20M4.7%
COM PAR $.01$11.59M4.1%
S&P BIOTECH$9.01M3.2%
Portfolio Concentration
Top 3$80.44M28.7%
4–10$103.43M37.0%
11–25$83.83M30.0%
Rest$12.11M4.3%
Top 3 weight
28.7%
Top 10 weight
65.7%
Voting Authority Distribution
Total shares with voting rights: 5.38M
Sole
Full voting authority
5.38M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole35
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings35
Rows:
NOVO-NORDISK A S
SOLEShares450K
TypeSH
Market value$38.71M
13.83%
Sole
450K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares494.42K
TypeSH
Market value$22.22M
7.94%
Sole
494.42K
Shared
0.00
None
0.00
MERUS N V
SOLEShares463.84K
TypeSH
Market value$19.50M
6.97%
Sole
463.84K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares219.72K
TypeSH
Market value$18.35M
6.56%
Sole
219.72K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares229.78K
TypeSH
Market value$17.62M
6.30%
Sole
229.78K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares204.04K
TypeSH
Market value$15.97M
5.71%
Sole
204.04K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares162.25K
TypeSH
Market value$13.28M
4.75%
Sole
162.25K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares56.40K
TypeSH
Market value$13.27M
4.74%
Sole
56.40K
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares190.75K
TypeSH
Market value$12.50M
4.47%
Sole
190.75K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares284.19K
TypeSH
Market value$12.43M
4.44%
Sole
284.19K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares255.32K
TypeSH
Market value$11.86M
4.24%
Sole
255.32K
Shared
0.00
None
0.00
INSMED INC
SOLEShares167.94K
TypeSH
Market value$11.59M
4.14%
Sole
167.94K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares293.85K
TypeSH
Market value$11.34M
4.05%
Sole
293.85K
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares100K
TypeSH
Market value$9.01M
3.22%
Sole
100K
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
SOLEShares162.98K
TypeSH
Market value$8.73M
3.12%
Sole
162.98K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares11.31K
TypeSH
Market value$6.96M
2.49%
Sole
11.31K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares45K
TypeSH
Market value$6.14M
2.20%
Sole
45K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares90.28K
TypeSH
Market value$3.63M
1.30%
Sole
90.28K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares50K
TypeSH
Market value$2.80M
1.00%
Sole
50K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares45.77K
TypeSH
Market value$2.34M
0.84%
Sole
45.77K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares102.90K
TypeSH
Market value$2.32M
0.83%
Sole
102.90K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares53.93K
TypeSH
Market value$1.95M
0.70%
Sole
53.93K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares100K
TypeSH
Market value$1.92M
0.69%
Sole
100K
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares54.52K
TypeSH
Market value$1.64M
0.59%
Sole
54.52K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares216.70K
TypeSH
Market value$1.61M
0.58%
Sole
216.70K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NOVO-NORDISK A SSOLE | ADR | 450K | SH | $38.71M 13.83% | 450K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 494.42K | SH | $22.22M 7.94% | 494.42K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 463.84K | SH | $19.50M 6.97% | 463.84K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 219.72K | SH | $18.35M 6.56% | 219.72K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 229.78K | SH | $17.62M 6.30% | 229.78K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 204.04K | SH | $15.97M 5.71% | 204.04K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 162.25K | SH | $13.28M 4.75% | 162.25K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 56.40K | SH | $13.27M 4.74% | 56.40K | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 190.75K | SH | $12.50M 4.47% | 190.75K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 284.19K | SH | $12.43M 4.44% | 284.19K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 255.32K | SH | $11.86M 4.24% | 255.32K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 167.94K | SH | $11.59M 4.14% | 167.94K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 293.85K | SH | $11.34M 4.05% | 293.85K | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P BIOTECH | 100K | SH | $9.01M 3.22% | 100K | 0.00 | 0.00 |
JANUX THERAPEUTICS INCSOLE | COM | 162.98K | SH | $8.73M 3.12% | 162.98K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 11.31K | SH | $6.96M 2.49% | 11.31K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 45K | SH | $6.14M 2.20% | 45K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 90.28K | SH | $3.63M 1.30% | 90.28K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 50K | SH | $2.80M 1.00% | 50K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 45.77K | SH | $2.34M 0.84% | 45.77K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 102.90K | SH | $2.32M 0.83% | 102.90K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 53.93K | SH | $1.95M 0.70% | 53.93K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 100K | SH | $1.92M 0.69% | 100K | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 54.52K | SH | $1.64M 0.59% | 54.52K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 216.70K | SH | $1.61M 0.58% | 216.70K | 0.00 | 0.00 |
Page 1 of 2